Novel use of high-flow nasal cannula therapy in the management of pyriform aperture stenosis: case report

Abstract

<jats:title>Abstract</jats:title><jats:sec id="S002221512000119X_sec_a1" sec-type="other"><jats:title>Background</jats:title><jats:p>Pyriform aperture stenosis is a rare form of congenital nasal obstruction; it poses a management dilemma for otolaryngologists and physicians alike. It can result in poor weight gain and potentially life-threatening airflow obstruction. The challenge lies in the difficulty to predict which patients will require invasive operative management versus conservative therapy alone.</jats:p></jats:sec><jats:sec id="S002221512000119X_sec_a2" sec-type="other"><jats:title>Case report</jats:title><jats:p>This case demonstrates the successful use of high-flow nasal cannula therapy in a young child with pyriform aperture stenosis.</jats:p></jats:sec>

An infrequent cause of neonatal upper airway obstruction: Congenital nasal pyriform aperture stenosis presenting to a remote facility

“…First‐line medical management includes topical nasal saline, intranasal decongestants, continuous positive airway pressure, or high flow nasal cannula therapy. 5 Pyriform aperture width of less than 5.7 mm is associated with a greater risk of invasive intervention, 6 Which typically involves sublabial endo‐oral incision and drill‐out of the inferolateral pyriform borders followed by intranasal stenting, with or without transnasal reduction of the inferior turbinates. 7 A transnasal dilation approach with reduced risks to surrounding structures as compared to open surgery was used in our case with good effect.…”